Advances in the development and evaluation of bovine herpesvirus 1 vaccines

Veterinary Microbiology

Volumn 53, Issue 1-2, 1996, Pages 43-54

  Van Oirschot, J T ^a   Kaashoek, M J ^a   Rijsewijk, F A M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Bovine herpesvirus 1; Efficacy; Eradication; Infectious bovine rhinotracheitis; Marker vaccines; Safety

Indexed keywords

HERPES VACCINE; VIRUS VACCINE;

BOVINE HERPES VIRUS; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HERPES VIRUS INFECTION; INFECTION CONTROL; INFECTIOUS BOVINE RHINOTRACHEITIS VIRUS; NONHUMAN; VACCINATION; VETERINARY MEDICINE;

ANIMALS; CATTLE; CATTLE DISEASES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS; PREVALENCE; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

BOS TAURUS; BOVINAE; BOVINE HERPESVIRUS 1; BOVINE RHINOTRACHEITIS VIRUS; HERPES; HERPESVIRIDAE; HERPESVIRUS 1;

EID: 0030292638     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(96)01233-3     Document Type: Conference Paper

References (60)

1. Baker, J.C., Rust, R.S. and Walker, R.D., 1989. Transmission of a vaccinal strain of infectious bovine rhinotracheitis virus from intranasally vaccinated steers commingled with nonvaccinated steers. Am. J. Vet. Res., 50: 814-816.
2. Bosch, J.C., De Jong, M.C.M., Maissan, J. and Van Oirschot, J.T., 1995a. Quantification of experimental transmission of bovine herpesvirus 1 in cattle vaccinated with marker vaccines. Proc. Symp. IBR and other Ruminant Herpesvirus Infections, Liège, July 26-27, p. 51.
3. Bosch, J.C., Frankena, K., Franken, P., Hage, J.J., De Jong, M.C.M., Kaashoek, M.J., Maris-Veldhuis, M.A., Noordhuizen, J.P.T.M., Van Der Poel, W.H.M., Verhoeff, J., Weerdmeester, K., Zimmer, G.M. and Van Oirschot, J.T., 1995b. Bovine herpesvirus 1 marker vaccines reduce the incidence of infections. Proc. Symp. IBR and other Ruminant Herpesvirus Infections, Liège, July 26-27, p. 50.
4. Bosch, J.C., Frankena, K. and Van Oirschot, J.T., 1996. Effect on milk production of vaccination with a bovine herpesvirus 1 gene-deleted inactivated vaccine. Vet. Rec., in press.
5. Brun, A., Dauvergne, M., Languet, B. and Reynaud, G., 1988. Studies of an inactivated vaccine prepared from viral subunits against infectious bovine rhinotracheitis virus. Med. Vet., 5: 583-586.
6. Bryan, L.A., Fenton, R.A., Misra, V. and Haines, D.M., 1994. Fatal, generalized bovine herpesvirus type-1 infection associated with a modified-live infectious bovine rhinotracheitis parainfluenza-3 vaccine administered to neonatal calves. Can. Vet. J., 35: 223-228.
7. Cox, G.J.M., Zamb, T.J. and Babiuk, L.A., 1993. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol., 67: 5664-5667.
8. Curtis, R.A. and Angulo, A., 1974. A field trial to evaluate an intranasal infectious bovine rhinotracheitis vaccine. Can. Vet. J., 15: 327-330.
9. De Jong, M.C.M. and Kimman, T.G., 1994. Experimental quantification of vaccine-induced reduction in virus transmission. Vaccine, 12: 761-766.
10. Duque, H., Marshall, R.L., Israel, B.A. and Letchworth, G.J., 1989. Effect of formalin inactivation on bovine herpesvirus 1 glycoproteins and antibody responses elicited by formalin-inactivated vaccines in rabbits. Vaccine, 7: 513-520.
11. Flores, E.F., Osorio, F.A., Zanella, E.L., Kit, S. and Kit, M., 1993. Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J. Vet. Diagn. Invest., 5: 534-540.
12. Frankena, K., Klaassen, C.H.L., Bosch, J.C., Van de Braak, A.E., Van de Haar, A.G.C., Van Tilburg, F.C. and Debouck, P., 1994. Double blind field evaluation of a trivalent vaccine against respiratory disease in veal calves. Vet. Q., 16: 148-152.
13. Frerichs, G.N., Woods, S.B., Lucas, M.H. and Sands, J.J., 1982. Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines. Vet. Rec., 111: 116-122.
14. Gao, Y., Leary, T.P., Eskra, L. and Splitter, G.A., 1994. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host. Vaccine, 12: 145-152.
15. George, L.W., Ardans, A., Mihalyi, J. and Guerra, M.R., 1988. Enhancement of infectious bovine keratocon-junctivitis by modified-live infectious bovine rhinotracheitis virus vaccine. Am. J. Vet. Res., 49: 1800-1806.
16. Gregersen, J.P. and Wagner, K., 1985. Persistent infection of the genital tract and excretion of the vaccine strain after live virus immunization with bovine herpesvirus 1 (IBR/IPV virus). Zentralbl. Vet. Med. B, 32: 354-360.
17. Halloran, M.E., Haber, M., Longini, Jr., I.M. and Struchiner J., 1991. Direct and indirect effects in vaccine efficacy and vaccine effectiveness. Am. J. Epidem., 133: 323-331.
18. Heffner, S., Kovacs, F., Klupp, B. and Mettenleiter, T., 1993. Glycoprotein gp50-negative pseudorabies virus: a novel approach towards a nonspreading live herpesvirus. J. Virol., 67: 1529-1537.
19. Hughes, H.P.A., Campos, M., Van Drunen Littel-van den Hurk, S., Zamb, T.J., Sordillo, L.M., Godson, D. and Babiuk, L.A., 1992. Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV. Vaccine, 10: 226-230.
20. Kaashoek, M.J. and Van Oirschot, J.T., 1996. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine. Vet. Microb. (this volume).
21. Kaashoek, M.J., Moerman, A., Madic, J., Rijsewijk, F.A.M., Quak, J., Gielkens, A.L.J. and Van Oirschot, J.T., 1994. A conventionally-attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine, 12: 439-444.
22. Kaashoek, M.J., Moerman, A., Madic, J.A., Weerdmeester, K., Maris-Veldhuis, M.A., Rijsewijk, F.A.M. and Van Oirschot, J.T., 1995a. An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine, 13: 342-346.
23. Kaashoek, M.J., Maris-Veldhuis, M.A., Magdalena, J., Rijsewijk, F.A.M. and Van Oirschot, J.T., 1995b. Non essential glycoproteins gC, gE and gI are expressed in all of 160 field isolates of bovine herpesvirus 1. Proc. 20th Int. Herpesvirus Workshop, Groningen, July 29-Aug 3, p. 95.
24. Kaashoek, M.J., Rijsewijk, F.A.M. and Van Oirschot, J.T., 1996. Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection. Vet. Microb. (this volume).
25. Kelling, C.L., Schipper, I.A., Strum, G.E., Carlson, R.B. and Tilton, G.E., 1973. Infectious bovine rhinotracheitis (IBR) abortion: observations on incidence in vaccinated and non-vaccinated and exposed cattle. Cornell Vet., 63: 383-389.
26. Kendrick, J.W., York, C.J. and McKercher, D.G., 1956. A controlled field trial of a vaccine for infectious bovine rhinotracheitis. Proc. U.S. Livestock San. Assoc., 60: 155-158.
27. Kit, S., 1988. Genetically engineered pseudorabies and infectious bovine rhinotracheitis virus vaccines. In: Technological advances in vaccine development. Alan R. Liss, pp. 183-195.
28. Kit, S., Qavi, H, Gaines, J.D., Billingsley, P. and McConnell, S., 1985. Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch. Virol., 86: 63-83.
29. Kit, M., Kit, S., Little, S.P., Di Marchi, R.D. and Gale, C., 1991. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine, 9: 564-572.
30. Kit, S., Otsuka, H. and Kit, M., 1992. Blocking ELISA for distinguishing infectious bovine rhinotracheitis virus (IBRV)-infected animals from those vaccinated with a gene-deleted marker vaccine. J. Virol. Method., 40: 45-56.
31. Kowalski, J., Gilbert, S.A., Van Drunen Littel-van Den Hurk, S., Van Den Hurk, J., Babiuk, L.A. and Zamb, T.J., 1993. Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells. Vaccine, 11: 1100-1107.
32. Kramps, J.A., Magdalena, J., Quak, J., Weerdmeester, K., Kaashoek, M.J., Maris-Veldhuis, M.A., Rijsewijk, F.A.M., Keil, G. and Van Oirschot, J.T., 1994. A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. J. Clin. Microb., 32: 2175-2181.
33. Lazarowicz, M., Steck, F., Ackermann, M. and Kihm, U., 1983. Testing of two vaccines against infectious bovine rhinotracheitis. Schweizer Arch. Tierheilkd., 125: 797-808.
34. Liang, X., Babiuk, L.A. and Zamb, T.J., 1992. An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing beta-galactosidase: Evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology, 189: 629-639.
35. Madin, S.H., York, C.J. and McKercher, D.G., 1956. Isolation of infectious bovine rhinotracheitis virus. Science, 124: 721-722.
36. Martin, W., Wilson, P., Curtis, R., Allen, B. and Acres, S., 1983. A field trial, of preshipment vaccination, with intranasal infectious bovine rhinotracheitis-parainfluenza-3 vaccines. Can. J. Comp. Med., 47: 245-249.
37. Meyer, H., Mayr, A., Bachmann, P.A., Bernardi, G. and Wagner, H., 1985. Schutzimpfung von latent IBR-IPV-Virus infizierten Bullen mit einer Vakzine aus inaktivertem IBR-Virus. Tierärztl. Umsch., 40: 974-985.
38. Miller, J.M., Whetstone, C.A., Bello, L.J. and Lawrence, W.C., 1991. Determination of the ability of a thymidine kinase-negative deletion mutant of bovine herpesvirus 1 to cause abortion in cattle. Am. J. Vet. Res., 52: 1038-1043.
39. Pastoret, P.P., Babiuk, L.A., Misra, V. and Griebel, P., 1980. Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone. Inf. Immun., 29: 483-488.
40. Peelers, B., Pol. J., Gielkens, A. and Moormann, R., 1993. Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. J. Virol., 67: 170-177.
41. Perrin, B., Calvo, T., Cordioli, P., Coudert, M., Edwards, S., Eloit, M., Guérin, B., Kramps, J.A., Lenihan, P., Paschaleri, E., Perrin, M., Schon, J., Van Oirschot, J.T., Vanopdenbosch, E., Wellemans, G., Wizigmann, G. and Thibier, M., 1994. Selection of European Union standard reference sera for use in the serological diagnosis of infectious bovine rhinotracheitis. Rev. Sci. Tech. Off. Int. Epiz., 13: 947-960.
42. Reddy, D.N., Reddy, P.G., Xue, W., Minocha, H.C., Daley. M.J. and Blecha, F., 1993. Immunopotentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2. Vet. Immunol. Immunopath., 37: 25-38.
43. Rijsewijk, F.A.M., Kaashoek, M.J., Madic, J., Paal, H., Ruuls, R., Gielkens, A.L.J. and Van Oirschot, J.T., 1993. Characterization of a DNA rearrangement found in the unique short region of the Za strain of bovine herpesvirus type 1 and the vaccine properties of this strain. Proc. 18th Int. Herpesvirus Workshop, Pittsburgh, July 25-30, p. C-67.
44. Rijsewijk, F., Kaashoek, M., Keil, G., Paal, H., Ruuls, R., Van Engelenburg, F. and Van Oirschot, J., 1994. In vitro and in vivo phenotypes and immunogenic properties of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI or gE gene. Proc. 19th Herpesvirus Workshop, Vancouver, July 30-Aug 5, p. 419.
45. Savan, M., Angulo, A.B. and Derbyshire, J.B., 1979. Interferon, antibody responses and protection induced by an intranasal infectious bovine rhinotracheitis vaccine. Can. Vet. J., 20: 207-210.
46. Sibbel, R.L., Bass, E.P. and Thomas, P.C., 1988. How long will a killed IBR vaccine protect against challenge? Vet. Med., 83: 90-92.
47. Straub, O.C., Funk, K. and Bruchhof, B., 1990. Challenge infection with IPV virus after inoculation of a bovine herpesvirus 1 subunit vaccine into cattle. Tierärztl. Umsch., 45: 383-388.
48. Strube, W., Auer, S., Abar, B., Bergle, R.D., Block, W., Heinen, E., Kretzdorn, D., Rodenbach, C. and Schmeer, N., 1994a. Infectious bovine rhinotracheitis marker vaccines - chemically inactivated and live attenuated - for the improvement of BHV1 control programs: 1. Safety aspects in the vaccine development. Proc. XVIII World Buiatrics Congr., Bologna, pp. 757-760.
49. Strube, W., Auer, S., Abar, B., Bergle, R.D., Block, W., Heinen, E., Kretzdorn, D., Rodenbach, C. and Schmeer, N., 1994b. Infectious bovine rhinotracheitis marker vaccines - chemically inactivated and live attenuated - for the improvement of BHV1 control programs: II. Evaluation of immunogenicity. Proc. XVIII World Buiatrics Congr., Bologna, pp. 761-764.
50. Sutton, M.L., 1980. Rapid onset of immunity in cattle after intramuscular injection of a modified-live-virus IBR vaccine. Vet. Med., 75: 1447-1456.
51. Talens, L.T., Beckenhauer, W.H., Thurber, E.T., Cooley, A.J. and Schultz, R.D., 1989. Efficacy of viral components of a nonabortigenic combination vaccine for prevention of respiratory and reproductive system diseases in cattle. J. Am. Vet. Med. Assoc., 194: 1273-1280.
52. Tamoglia, T.W., 1968. Laboratory evaluation of bovine respiratory disease vaccines for safety. J. Am. Vet. Med. Assoc., 152: 847-850.
53. Terpstra, C., Eikelenboom, J.L. and Glas, C., 1982. Experiences with early vaccination of fattening calves against infectious bovine rhinotracheitis, bovine virus diarrhoea and parainfluenza type 3. Proc. XIIth World Congr. Dis. Cattle, Utrecht, pp. 171-175.
54. Todd, J.D., Volenec, F.J. and Paton, I.M., 1972. Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Inf. Immun., 5: 699-706.
55. Van Drunen Littel-van den Hurk, S., Tikoo, S.K., Liang, X. and Babiuk, L.A., 1993. Bovine herpesvirus-1 vaccines. Immunol. Cell Biol., 71: 405-420.
56. Van Drunen Littel-van den Hurk, S., Van Donkersgoed, J., Kowalski, J., Van den Hurk, J.V., Harland, R., Babiuk, L.A. and Zamb, T.J., 1994. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle. Vaccine, 12: 1295-1302.
57. Van Engelenburg, F.A.C., Kaashoek, M.J., Rijsewijk, F.A.M., Van den Burg, L., Moerman, A., Gielkens, A.L.J. and Van Oirschot, J.T., 1994. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves. J. Gen. Virol., 75: 2311-2318.
58. Van Engelenburg, F.A.C., Kaashoek, M.J., Van Oirschot, J.T. and Rijsewijk, F.A.M., 1995. A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. J. Gen. Virol., 76: 2387-2392.
59. Whetstone, C.A., Wheeler, J.G. and Reed, D.E., 1986. Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA. Am. J. Vet. Res., 47: 1789-1795.
60. Zygraich, N., Lobmann, M, Vacoboinic, E., Berge, E. and Huygelen, C., 1974. In vivo and in vitro properties of a temperature sensitive mutant of infectious bovine rhinotracheitis virus. Res. Vet. Sci., 16: 328-335.